A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload.

作者:Rienhoff Hugh Y Jr; Viprakasit Vip; Tay Lay H; Harmatz Paul; Vichinsky Elliott; Chirnomas Deborah; Kwiatkowski Janet; Tapper Amy E; Porter John B; Neufeld Ellis J
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19